Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,220,009
-
Share change
-
+1,189,145
-
Total reported value
-
$211,113,995
-
Price per share
-
$12.26
-
Number of holders
-
55
-
Value change
-
+$9,671,156
-
Number of buys
-
30
-
Number of sells
-
27
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q4 2016
As of 31 Dec 2016,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,220,009 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, NEA Management Company, LLC, FMR LLC, JENNISON ASSOCIATES LLC, Hillhouse Capital Management, Ltd., FIL Ltd, Rock Springs Capital Management LP, MARSHALL WACE, LLP, VANGUARD GROUP INC, and FRANKLIN RESOURCES INC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.